CERTL reduces C16 ceramide, amyloid-β levels and inflammation in a model of Alzheimer's disease
Additive interaction of mid- to late-life depression and cerebrovascular disease on the risk of dementia: A nationwide population-based cohort study
Sleep Treatment Improves Neuropsychological Symptoms and Reduces Blood Aβ42/pTau Protein in Alzheimer's Disease Patients: a Longitudinal Study
Plasma Neurofilament Light and Phosphorylated Tau 181 as Biomarkers of Alzheimer’s Disease Pathology and Clinical Disease Progression
Identification of and a Prediction Model for Cognitive Trajectories in Patients With Mild Cognitive Impairment Due to Alzheimer’s Disease
An Integrative Multi-omics Approach Reveals New Central Nervous System Pathway Alterations in Alzheimer’s Disease
Performance of the QPLEXTM Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition
Identification of Mild Cognitive Impairment Subtypes Predicting Conversion to Alzheimer’s Disease Using a Heterogeneous Mixture Learning
A Strategy for Identifying the Risk of Developing Alzheimer's Disease From Healthy Controls: Distance to Novelty Detection Boundary
Use of the Clock Drawing Test and the Rey–Osterrieth Complex Figure Test-copy With Convolutional Neural Networks to Predict Cognitive Impairment
Learn more about Alzheimer's Research and Therapy